Frederick W.K. Brown
Managing Director, Healthcare
Expertise
Mr. Brown is a global leader in healthcare business management and consulting. His influence in the U.S., Europe and emerging markets transforms business plans to profits, with his proven ability to lead and coach executive teams, develop and implement multifunctional strategy programs and create and launch new businesses. He brings a unique breadth and depth of analysis, strategy and implementation know-how to clients seeking to capitalize on developments in healthcare and technology.
More than 50 partners are successful in global markets, thanks in part to Mr. Brown’s guidance in developing, launching and managing dozens of healthcare product and service lines. His leadership is generating $15 billion in annual revenue for pharmaceutical drug portfolios and his work impacts an estimated 5.5 million lives annually around the globe.
Mr. Brown’s capabilities are valued across provider, payor, pharmaceutical and medical product markets. He is passionate about developing and implementing winning competitive and operational strategies for his clients across the healthcare value chain.
Impact
With a distinguished 30-year career in the healthcare industry working in various operating and consulting positions, Mr. Brown most recently led the healthcare services division of the largest privately-owned specialty pharmacy in the U.S. As President of Navigator Health Services for Diplomat Specialty Pharmacy, he improved EBITDA by over 25 percent while helping implement a growth strategy that won Diplomat the INC 500 award for “Fastest Growing Healthcare Company in the US in 2009 and 2010.
As Global Head of Product Lifecycle Management and Partnering IM at Hoffman LaRoche, Mr. Brown contributed to a 7% overall corporate year-on-year profitability increase by implementing a new portfolio and partnering strategy. In addition, Mr. Brown implemented new sales and marketing organizations, reducing costs 30% while improving service metrics by over 80%.
As a top healthcare consultant, Mr. Brown served as Executive Vice President of Global Service EMEA for IBM’s Life Sciences Division. Mr. Brown grew the division from less than $1Million to more than $1.2 Billion across 62 countries in Europe, the Middle East and African (EMEA) Markets in three years. Earlier in his career, Mr. Brown was a Partner and co-founded Andersen Consulting’s (Accenture) Pharmaceutical and Medical Products Practice in the United States and Europe.
Early in his career, Mr. Brown founded and led the world’s largest in depoinjection company Alkermes, now a public company valued at over $1B.
Foundation
Mr. Brown is a regular speaker at international healthcare conferences, and a member of the board of directors of several healthcare companies. He is a graduate of the Harvard Business School with a Masters of Business Administration, and completed his Bachelor of Science in Biology and Geology at Tufts University, As a grant recipient and principal investigator for the NSF, Mr. Brown led a team of medicinal neurochemistsin discovering drugs to treat degenerative diseases of the central nervous system.
Mr. Brown is Six Sigma and Project Management certified, and is Lean trained. He was listed in the “Who’s Who International” from 2002-2004. A citizen of the United States and Switzerland, Mr. Brown is fluent in both German and English.